National Foundation for Cancer Research (NFCR) fellow Dr. Paul Fisher has been instrumental in NFCR’s mission to combat metastasis, a major cause of cancer morbidity. He has dedicated his career to this mission and recently published a game-changing study that may alter the lives of many – especially those with breast and prostate cancer.…...
Exercise plays an important role in preventing a variety of cancers. A recent study has increased the importance of maintaining a well-balanced and active lifestyle – indicating a positive outlook for many breast cancer patients. National Foundation for Cancer Research (NFCR)-funded scientist Dr. Rakesh Jain, and his team at Massachusetts General Hospital and Harvard Medical…...
Natural Killer (NK) cells are specialized lymphocytes that play critical roles in the immune response against abnormal cells, including all kinds of cancer cells. Different from T cells that need to be pre-activated by antigen-presenting cells before gaining the killing power, NK cells can quickly respond to a wide variety…...
Any illness or disease that impacts the brain is highly complex. None more so than brain tumors, which affect over 20,000 Americans each year. While surgeons have become more advanced in the removal of brain tumors, experts continue to face extreme challenges in ensuring all cancerous tissues are removed during surgery. That…...
Dubbed one of the notorious ‘silent killers’, ovarian cancer claims the lives of approximately 14,000 American women each year. Tragically, all women are at risk and early detection and sustainable treatment have proved to be difficult. However, a recent study provides new hope in the realm of ovarian cancer treatment.…...
When people hear the word “vaccine”, they often think about vaccine’s preventive function that protects people from getting infectious diseases such as flu, hepatitis or Covid-19. It’s true that traditional vaccines are developed to prevent infectious diseases, but innovative scientists are developing therapeutic vaccines that can treat various non-infectious diseases,…...
NEW NFCR-Supported Technology is Ready for Clinical Use With a better understanding of the genetic changes in cancer cells, and a more effective way to capture them, oncologists and scientists can be alerted to drug resistance and metastasis —allowing them to more quickly select new drugs or better therapies for…...
Immuno-oncology (IO) drugs have demonstrated unprecedented benefits in the treatment of several types of cancer. The overall survival time of cancer patients treated by IO drugs have been dramatically extended, and in some cases, even late stage fatal cancers are brought into remission by the IO-based immunotherapy. IO drugs work…...
Free Cancer Screening Guidelines
National Foundation for Cancer Research(NFCR) is a 501(c)(3) tax-exempt nonprofit organization.
Tax ID #: 04-2531031
5515 Security Lane, Suite 1105 Rockville, MD 20852
